Corning has led a $34m round for NinePoint Medical, a manufacturer of in-vivo pathology devices, bringing its overall funding to $67m.
US-based medical device maker NinePoint Medical has closed $34m in series B financing led by glass and ceramics maker Corning Incorporated.
NinePoint Medial works to improve patient care through the development of medical devices that enable high-resolution in-vivo imaging. The latest financing round also saw re-investment from venture capital firms Third Rock Ventures and Prospect Venture Partners, both existing investors.
The series B round brings NinePoint’s total funding to $67m. The company also announced the addition of three new members…
